PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 18, 2026CureusOpen Access

Screening for Hepatic Steatosis and Fibrosis Among Physicians Attending the Integrated Diabetes and Endocrine Academy Conference: A Cross-Sectional Study

View Full Paper
Ask AI
Bookmark
Share

Authors

BSBinayak SinhaSGSamit GhosalSRSoumyabrata RoyChaudhuri

Discussion

Loading...

Member takes

Overview

Cross-sectional study assesses FIB-4 screening efficacy for fibrosis in obese physicians, suggesting the need for combined evaluations.

Key Points

  • This study aims to evaluate the effectiveness of the FIB-4 score for screening advanced hepatic fibrosis in physicians with obesity.
  • Cross-sectional analysis of 161 physicians attending IDEACON to assess demographics, anthropometrics, and laboratory parameters.
  • Utilization of FibroScan for measuring controlled attenuation parameter and liver stiffness measurement.
  • Comparison of FIB-4 diagnostic performance against CAP and LSM-defined outcomes for hepatic steatosis and fibrosis.
  • FIB-4 displayed poor sensitivity (6.3% for LSM F3/F4, 5.1% for S3 fibrosis) and AUCs of 0.51 and 0.49, but high specificity (95.7%).
  • WC and ALT were significant predictors for CAP S3, with ORs of 1.09 (p=0.036) and 1.05 (p=0.013) respectively.
  • Diabetes presence significantly predicted LSM F4 with an OR of 33.34 (p=0.010).

Cite This Study

Sinha et al. (2026) studied this question.

synapsesocial.com/papers/6a338b22630953a74978ccdbhttps://doi.org/10.7759/cureus.110948
View Full Paper
Ask AI
Bookmark
Share